|
ZWINT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37359999935671E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.25389999955972E-07 |
| Normal-vs-Stage2 |
1.242780E-01 |
| Normal-vs-Stage3 |
4.007200E-04 |
| Normal-vs-Stage4 |
2.99740000042625E-07 |
| Stage1-vs-Stage2 |
4.906400E-02 |
| Stage1-vs-Stage3 |
8.487000E-01 |
| Stage1-vs-Stage4 |
1.006450E-02 |
| Stage2-vs-Stage3 |
9.280300E-02 |
| Stage2-vs-Stage4 |
5.963600E-04 |
| Stage3-vs-Stage4 |
3.480200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.0304999953934E-08 |
| Normal-vs-AfricanAmerican |
2.131600E-02 |
| Normal-vs-Asian |
1.350610E-01 |
| Caucasian-vs-AfricanAmerican |
4.110000E-01 |
| Caucasian-vs-Asian |
4.337600E-01 |
| AfricanAmerican-vs-Asian |
1.767550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.95119999993432E-07 |
| Normal-vs-Female |
6.98050000025319E-07 |
| Male-vs-Female |
7.572800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.761800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.59320000028929E-07 |
| Normal-vs-Age(61-80Yrs) |
2.88489999999975E-06 |
| Normal-vs-Age(81-100Yrs) |
9.639700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.110600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.016000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.420400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.598000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.799400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.301600E-03 |
| Normal-vs-Grade 2 |
2.32659999999107E-05 |
| Normal-vs-Grade 3 |
4.22349999995575E-06 |
| Normal-vs-Grade 4 |
4.32750000001203E-06 |
| Grade 1-vs-Grade 2 |
5.659800E-01 |
| Grade 1-vs-Grade 3 |
9.116400E-01 |
| Grade 1-vs-Grade 4 |
1.253980E-01 |
| Grade 2-vs-Grade 3 |
3.244200E-01 |
| Grade 2-vs-Grade 4 |
6.418600E-03 |
| Grade 3-vs-Grade 4 |
2.816400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.02990000000214E-05 |
| Normal-vs-ccB subtype |
4.28040000000074E-05 |
| ccA subtype-vs-ccB subtype |
1.815020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.32059999999623E-07 |
| Normal-vs-N1 |
1.216420E-03 |
| N0-vs-N1 |
2.277800E-02 |
|
|
